This content is restricted.
Brief
On 17/07/2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding Five non-executive directors reappointed to the Medicines and Healthcare products Regulatory Agency Board. The reappointments will bring continuity to the board as it advises on strategic direction and ensures high standards of corporate governance, maintaining a time commitment of 2-3 days per month, with remuneration rates of £7,883 and £13,137 per year for non-executive directors and Audit Chair respectively.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
